Brokerages count on Johnson & Johnson (NYSE:JNJ) to publish $21.82 billion in gross sales for the present fiscal quarter, Zacks Funding Analysis experiences. 4 analysts have supplied estimates for Johnson & Johnson’s earnings. The best gross sales estimate is $22.05 billion and the bottom is $21.44 billion. Johnson & Johnson reported gross sales of $20.75 billion throughout the identical quarter final 12 months, which might counsel a constructive 12 months over 12 months progress charge of 5.2%. The enterprise is predicted to announce its subsequent quarterly earnings report on Wednesday, January 27th.
Based on Zacks, analysts count on that Johnson & Johnson will report full-year gross sales of $81.92 billion for the present monetary 12 months, with estimates starting from $81.55 billion to $82.16 billion. For the subsequent 12 months, analysts count on that the corporate will publish gross sales of $88.85 billion, with estimates starting from $87.57 billion to $90.10 billion. Zacks Funding Analysis’s gross sales averages are a median primarily based on a survey of analysis analysts that observe Johnson & Johnson.
Johnson & Johnson (NYSE:JNJ) final posted its quarterly earnings outcomes on Sunday, October 18th. The corporate reported $2.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.98 by $0.22. The agency had income of $21.08 billion through the quarter, in comparison with analyst estimates of $20.15 billion. Johnson & Johnson had a return on fairness of 34.64% and a web margin of 21.01%. Johnson & Johnson’s quarterly income was up 1.7% in comparison with the identical quarter final 12 months. Throughout the identical quarter within the earlier 12 months, the agency earned $2.12 EPS.
A number of analysis companies have lately issued experiences on JNJ. Raymond James reaffirmed a “purchase” ranking on shares of Johnson & Johnson in a analysis report on Friday, November 20th. Cantor Fitzgerald lifted their price goal on Johnson & Johnson from $168.00 to $180.00 and gave the stock an “chubby” ranking in a report on Wednesday, October 14th. Stifel Nicolaus downgraded Johnson & Johnson from a “purchase” ranking to a “maintain” ranking in a report on Wednesday, August 19th. Lastly, Credit score Suisse Group lifted their price goal on Johnson & Johnson from $163.00 to $168.00 and gave the stock an “outperform” ranking in a report on Wednesday, October 14th. One analysis analyst has rated the stock with a promote ranking, 4 have issued a maintain ranking and ten have given a purchase ranking to the stock. Johnson & Johnson has a median ranking of “Purchase” and a consensus price goal of $164.93.
Hedge funds have lately purchased and offered shares of the corporate. Newfound Analysis LLC bought a brand new place in shares of Johnson & Johnson through the third quarter valued at about $28,000. Essex Funding Administration Co. LLC bought a brand new place in Johnson & Johnson within the third quarter worth roughly $37,000. Islay Capital Administration LLC bought a brand new place in Johnson & Johnson within the 2nd quarter worth roughly $42,000. FAI Wealth Administration lifted its holdings in Johnson & Johnson by 45.9% within the 2nd quarter. FAI Wealth Administration now owns 321 shares of the corporate’s stock worth $45,000 after buying a further 101 shares within the final quarter. Lastly, Crewe Advisors LLC lifted its holdings in Johnson & Johnson by 909.1% within the third quarter. Crewe Advisors LLC now owns 333 shares of the corporate’s stock worth $50,000 after buying a further 300 shares within the final quarter. 61.26% of the stock is at the moment owned by hedge funds and different institutional buyers.
JNJ opened at $153.10 on Thursday. The stock has a 50-day transferring common price of $144.96 and a 200-day transferring common price of $146.41. The corporate has a debt-to-equity ratio of 0.51, a present ratio of 1.48 and a fast ratio of 1.24. The agency has a market cap of $403.04 billion, a PE ratio of 24.07, a P/E/G ratio of three.10 and a beta of 0.69. Johnson & Johnson has a 1 12 months low of $109.16 and a 1 12 months excessive of $157.00.
The enterprise additionally lately disclosed a quarterly dividend, which was paid on Tuesday, December eighth. Stockholders of report on Tuesday, November 24th got a dividend of $1.01 per share. The ex-dividend date was Monday, November 23rd. This represents a $4.04 dividend on an annualized foundation and a dividend yield of two.64%. Johnson & Johnson’s payout ratio is at the moment 46.54%.
About Johnson & Johnson
Johnson & Johnson researches and develops, manufactures, and sells numerous merchandise within the well being care area worldwide. It operates in three segments: Shopper, Pharmaceutical, and Medical Gadgets. The Shopper section affords child care merchandise underneath the JOHNSON’S model; oral care merchandise underneath the LISTERINE model; magnificence merchandise underneath the AVEENO, CLEAN & CLEAR, DR.
See Additionally: The function of implied volatility with name possibility quantity
Get a free copy of the Zacks analysis report on Johnson & Johnson (JNJ)
For extra details about analysis choices from Zacks Funding Analysis, go to Zacks.com
This immediate information alert was generated by narrative science know-how and monetary information from MarketBeat with a purpose to present readers with the quickest and most correct reporting. This story was reviewed by MarketBeat’s editorial workforce previous to publication. Please ship any questions or feedback about this story to [email protected]